Interleukin-1-receptor antagonist in the Muckle-Wells syndrome [PDF]
, 2003 Hawkins, PN, Lachmann, HJ, McDermott, MF
core +1 more source
Interleukin 1 alters guinea pig tracheal smooth muscle responsiveness to β-adrenergic stimulation
, 1990 Marsha Wills‐Karp +3 more
openalex +1 more source
Advanced Healthcare Materials, EarlyView.This review summarizes the roles of key central nervous system cell types, the extracellular matrix, and the blood‐brain barrier in neuroinflammation, and their integration into diverse 3D culture systems. It examines major incorporation strategies, including direct co‐culture, hydrogel encapsulation, transwell migration assays, and bioprinting ...
Emmanuelle D. Aiyegbusi +2 more
wiley +1 more source
The role of interleukin-1 and granulocyte-macrophage colony-stimulating factor in the paracrine stimulation of an in vivo-derived murine myeloid leukemia [PDF]
, 1991 KB Leslie, HJ Ziltener, JW Schrader
openalex +1 more source
The Safety and Efficacy of the Interleukin-1 Antagonist Anakinra in Severe Cases of COVID-19- A Systematic Review and Meta-analysis. [PDF]
, 2020 Manoj Kumar Reddy Somagutta +16 more
openalex +1 more source
Advanced Healthcare Materials, EarlyView.A long‐lived, five‐cell‐type human neurovascular (PENTA) model recreates vascular disorganization and incomplete repair after traumatic brain injury (TBI). By integrating endothelial, glial, neuronal, and immune components within a 3D scaffold, the platform enables time‐resolved analysis of neurovascular remodeling and provides a human‐relevant system ...
Daniel S. Hinrichsen +6 more
wiley +1 more source
Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1.
, 1992 Stephen Kent +6 more
openalex +2 more sources
Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor Ia of lipid A [PDF]
, 1992 W Feist
openalex +1 more source
Design and Synthesis of Peptide‐Polyester Conjugates for Cell‐Mediated Scaffold Degradation
Advanced Healthcare Materials, EarlyView.This work describes polycaprolactone (PCL)‐based biomaterials engineered to degrade in response to cell‐secreted proteases. A fast‐degrading peptide (Fast) sequence is integrated into a PCL conjugate backbone to produce a biomaterial that is selectively degraded by multiple cell types compared to its scrambled control (ScrFast).
Korina Vida G. Sinad +7 more
wiley +1 more source
Regulation of the synthesis of nerve growth factor (NGF) by interleukin-1 (IL-1) [PDF]
, 1992 Bandtlow, Christine +6 more
core +1 more source